ערך בספרים למניה: Palisade Bio (PALI)

Palisade Bio, Inc. (PALI) generates revenue through the development of agents for post-surgical intestinal recovery. The book value per share reflects capital dynamics, with the value fixed at 0.70. The use of AI for molecule discovery within a narrow inflammation segment protects the business from generics. However, aggressive competition with pharma behemoths in the hospital sector creates significant risks.

Amid intense patent battles for the fibrosis therapy market, the actual value of the intellectual property and assets of Palisade Bio, Inc. (PALI) is critical for assessing business resilience. This metric is calculated as the difference between total assets and liabilities divided by the number of shares, which allows an analysis of the book value per share to determine the intrinsic value of the security and avoid overpaying for market expectations.